Design and analysis considerations for combining data from multiple biomarker studies. 2019

Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Pooling data from multiple studies improves estimation of exposure-disease associations through increased sample size. However, biomarker exposure measurements can vary substantially across laboratories and often require calibration to a reference assay prior to pooling. We develop two statistical methods for aggregating biomarker data from multiple studies: the full calibration method and the internalized method. The full calibration method calibrates all biomarker measurements regardless of the availability of reference laboratory measurements while the internalized method calibrates only non-reference laboratory measurements. We compare the performance of these two aggregation methods to two-stage methods. Furthermore, we compare the aggregated and two-stage methods when estimating the calibration curve from controls only or from a random sample of individuals from the study cohort. Our findings include the following: (1) Under random sampling for calibration, exposure effect estimates from the internalized method have a smaller mean squared error than those from the full calibration method. (2) Under the controls-only calibration design, the full calibration method yields effect estimates with the least bias. (3) The two-stage approaches produce average effect estimates that are similar to the full calibration method under a controls only calibration design and the internalized method under a random sample calibration design. We illustrate the methods in an application evaluating the relationship between circulating vitamin D levels and stroke risk in a pooling project of cohort studies.

UI MeSH Term Description Entries
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios

Related Publications

Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
May 2023, NEJM evidence,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
September 2020, The annals of applied statistics,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
August 2021, Statistical methods in medical research,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
June 2015, Bioinformatics (Oxford, England),
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
February 2013, Journal of pediatric surgery,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
June 2022, Cancers,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
July 2022, Epidemiology (Cambridge, Mass.),
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
January 2006, Journal of biopharmaceutical statistics,
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
July 2021, Biostatistics (Oxford, England),
Abigail Sloan, and Yue Song, and Mitchell H Gail, and Rebecca Betensky, and Bernard Rosner, and Regina G Ziegler, and Stephanie A Smith-Warner, and Molin Wang
April 2015, Journal of dairy science,
Copied contents to your clipboard!